Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma (KS): implications for the design of therapeutic trials in patients with advanced symptomatic KS.
Nasti
Guglielmo
G
Tirelli
Umberto
U
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D023241:Antiretroviral Therapy, Highly Active; D006801:Humans; D018579:Patient Selection; D011379:Prognosis; D012107:Research Design; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000209:etiology / Q000821:virology*; D016019:Survival Analysis